SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in ...
Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...
SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...
The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an eosinophilic phenotype, according to a press release from GSK.Depemokimab ...
A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...
Blue Cross Blue Shield is changing how some asthma injections are given, sparking concerns from doctors. Blue Cross Blue Shield (BCBS), under its parent company Health Care Service Corporation, is ...
New ‘life-changing’ asthma drug gets green light after rise in hospital admissions - A trial cut hospital admissions by 72 ...
An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...
The Associated Press reported that Xolair is the name brand for omalizumab and is given by injection and can be used to lessen the effects of reactions when someone is accidentally exposed to ...
There's been *** rise in childhood food allergies in recent years affecting Children nationwide. These 12 Long Island investigative reporter Rachel Yank Kunis is here now to break down the numbers for ...
Seattle protests U.S. military operation in Venezuela amid Maduro capture, strikes As Venezuelans around the world celebrate the capture of Nicolas Maduro, people in Seattle took to the streets to ...
About 20 million people in the U.S.—including four million children—have food allergies. Now, there's a new way to reduce their risk of severe allergic reactions. A study published in the New England ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results